We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$244B
AUM Growth
-$56.4B
Cap. Flow
-$9.23B
Cap. Flow %
-3.79%
Top 10 Hldgs %
13.08%
Holding
11,816
New
1,264
Increased
3,667
Reduced
5,054
Closed
1,052

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$641M
2
MSFT icon
Microsoft
MSFT
+$477M
3
ACN icon
Accenture
ACN
+$354M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$332M
5
CVX icon
Chevron
CVX
+$304M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Healthcare 7.02%
3 Financials 6.95%
4 Consumer Discretionary 5.19%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRSN icon
6001
NeuroSense Therapeutics
NRSN
$18M
$45K ﹤0.01%
13,428
+11,544
+613% +$21.9K
SRPT icon
6002
CALL
Sarepta Therapeutics
SRPT
$1.77B
$45K ﹤0.01%
+600
New +$44.1K
SUPN icon
6003
Supernus Pharmaceuticals
SUPN
$2.77B
$45K ﹤0.01%
1,584
-82,180
-98% -$2.35M
XBIT icon
6004
XBiotech
XBIT
$69.2M
$45K ﹤0.01%
8,063
-388
-5% -$2.61K
KCGI
6005
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$45K ﹤0.01%
4,501
+3,776
+521% +$37.4K
POSH
6006
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$45K ﹤0.01%
4,496
-2,261
-33% -$26.1K
ERUS
6007
DELISTED
iShares MSCI Russia ETF
ERUS
$45K ﹤0.01%
5,610
-3,256
-37% -$26.1K
AXDX
6008
DELISTED
Accelerate Diagnostics
AXDX
$44K ﹤0.01%
4,359
+3,964
+1,004% +$35K
BDTX icon
6009
Black Diamond Therapeutics
BDTX
$112M
$44K ﹤0.01%
17,599
-3,221
-15% -$7.49K
CTRN icon
6010
Citi Trends
CTRN
$605M
$44K ﹤0.01%
1,851
-19,333
-91% -$545K
FIX icon
6011
Comfort Systems
FIX
$59.6B
$44K ﹤0.01%
533
-193
-27% -$16.6K
FNOV icon
6012
FT Vest US Equity Buffer ETF November
FNOV
$1.24B
$44K ﹤0.01%
+1,302
New +$46.4K
GFF icon
6013
Griffon
GFF
$4.86B
$44K ﹤0.01%
1,557
-984
-39% -$24.8K
GPOR icon
6014
Gulfport Energy Corp
GPOR
$2.88B
$44K ﹤0.01%
556
-24,527
-98% -$2.28M
IGEB icon
6015
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
$44K ﹤0.01%
+994
New +$45.5K
MBSD icon
6016
FlexShares Disciplined Duration MBS Index Fund
MBSD
$88.9M
$44K ﹤0.01%
2,079
-1,814
-47% -$38.7K
MITT
6017
TPG Mortgage Investment Trust
MITT
$225M
$44K ﹤0.01%
6,500
-177
-3% -$1.36K
MOG.A icon
6018
Moog Inc Class A
MOG.A
$12.8B
$44K ﹤0.01%
552
-535
-49% -$43.3K
NXTC icon
6019
NextCure
NXTC
$26.7M
$44K ﹤0.01%
777
+14
+2% +$731
OVS icon
6020
Overlay Shares Small Cap Equity ETF
OVS
$36.6M
$44K ﹤0.01%
1,525
+1,516
+16,844% +$47.7K
SCM icon
6021
Stellus Capital Investment Corp
SCM
$243M
$44K ﹤0.01%
3,948
+2,856
+262% +$36.9K
EXEEW
6022
DELISTED
Expand Energy Corp Class A Warrants
EXEEW
$44K ﹤0.01%
727
+147
+25% +$10.2K
AMK
6023
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$44K ﹤0.01%
2,321
-4,611
-67% -$92.2K
OTEC
6024
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$44K ﹤0.01%
+4,395
New +$44.3K
CPARU
6025
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$44K ﹤0.01%
4,453
-842
-16% -$8.29K

Similar funds

UBS Group's Q2 2022 Portfolio in Review

As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $9.23B in Q2 2022, closing 1,052 positions and reducing 5,054 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.

  • UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
  • UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
  • UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
  • UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
  • UBS Group opened 1,264 new positions and closed 1,052 in Q2 2022.
  • UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.